Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nanuli Gvazava"'
Publikováno v:
Case Reports in Infectious Diseases, Vol 2023 (2023)
Lemierre syndrome (LS) is a rare, serious infection that is often misdiagnosed, as it frequently mimics common upper respiratory infections. It is even rarer for LS to be preceded by a viral infection. We share a case of LS in a young man who present
Externí odkaz:
https://doaj.org/article/18f6c59cacb34004b45dc0ffc3f4fd6f
Autor:
Cherian Verghese, Weihong Li, Nanuli Gvazava, Emmanouil Alimpertis, Navkirat Kahlon, Hongliu Sun, Robert Booth
Publikováno v:
Clinical Pathology, Vol 15 (2022)
Splenic lymphoma may be primary or secondary. Primary splenic lymphoma’s are rare and usually of follicular cell origin representing
Externí odkaz:
https://doaj.org/article/0b148d7c028544adacf1f7f81b870871
Background:Von Hippel-Lindau disease is an autosomal dominant disorder characterized by development of variety of benign and malignant tumors and cysts including brain stem, cerebellum, spinal cord as well as pancreas, kidneys, and retina. The most c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::232fee6ea02f9be42f6db2fe21aecd00
https://doi.org/10.21203/rs.3.rs-1514702/v1
https://doi.org/10.21203/rs.3.rs-1514702/v1
Autor:
Zahid Tarar, Pak Ho Au, Kelechi Nwabara, Diana Franco, Peter Egwom, Nanuli Gvazava, Mohammad Saleh, Ghulam Ghous
Publikováno v:
Journal of Clinical Oncology. 40:e18801-e18801
e18801 Background: Clostridioides difficile infection (CDI) is notorious for its perilous effect on frail patients, but its assault is even more so threatening on cancer patients as they are more prone to CDI due to damage to intestinal mucosa by che
Autor:
Ghulam Ghous, Nanuli Gvazava, Peter Egwom, Mohammad Saleh, Diana Franco, Hafiz Muhammad Hassan Shoukat, Pak Ho Au, Kelechi Nwabara, Zahid Tarar
Publikováno v:
Journal of Clinical Oncology. 40:e19524-e19524
e19524 Background: CLL accounts for about one-quarter of the new cases of leukemia and affects mainly elderly population. Recent literature highlights increased cardiovascular events in patients with CLL, notably those being treated with targeted the